from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0927c/-

LFCtreatmentdescriptionclass of inhibitor

0.099

Amikacinug/mL Amikacintranslation

0.544

Cap5-10ug/mL Capreomycintranslation

1.150

Rox10-50 ug/mL Roxithromycintranslation

-0.403

SM2-5 ug/mL Streptomycintranslation

-1.354

Tet5-10 ug/mL Tetracyclinetranslation

0.691

Rif0.2-5ug/mL Rifampicintranscription

0.502

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.791

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.345

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.487

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.710

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.063

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.577

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.256

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.127

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.434

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.594

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.761

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.043

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.350

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.584

KCN5-20 ug/mL Potassium cyaniderespiration

-0.890

NaN30.2-2 mM Sodium aziderespiration

0.178

Nigericin50 uM Nigericinrespiration

0.419

TRC10-150 ug/mL Triclosanrespiration

-0.143

TRZ10-25 ug/mL Thioridazinerespiration

-1.267

Valinomycin0.5-10 uM Valinomycinrespiration

2.439

ZnSO42 mM ZnSO4respiration

-0.712

menadione6-10 ug/mL Menadionerespiration

-0.737

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.289

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.139

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.354

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.538

NRP_1Non-replicating persistence stage 1dosRassociated

-0.097

Amp0.2mg/mL AmpicillincellWall

0.646

Cephalexin20-100 ug/mL CephalexincellWall

-0.029

Cerulenin0.32-5 ug/mL CerulenincellWall

1.035

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.067

EMB10-20 ug/mL EthambutolcellWall

0.050

Eta12-40 ug/mL EthionamidecellWall

-0.327

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.002

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.161

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.209

BZA0.12 mg/mL BenzamidearomaticAmides

0.196

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.360

H2O24 mM hydrogen peroxideDNAdamaging

-0.028

Levo10 ug/mL LevofloxacinDNAdamaging

-0.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.892

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.173

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.207

UVUV-irradiationDNAdamaging

-1.543

ARP41-4 ug/mL Antitubercular compound ARP4?

0.247

Antimycin12.5-50 ug/mL Antimycin A?

0.749

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.017

PA_110-50 ug/mL Antitubercular compound PA-1?

0.816

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.489

PA8240.2-2 ug/mL PA-824?

-0.402

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.044

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.387

Verapamil50 uM Verapamil?

0.299

mercaptoethanol2 mM 2-Mercaptoethanol?

0.285

methoxatin10-20 ug/mL Methoxatin?